Mechanistic insights into cardiac regeneration and protection through MEIS inhibition
2024

Cardiac Regeneration and Protection through MEIS Inhibition

publication 10 minutes Evidence: high

Author Information

Author(s): MAMMADOVA Aynura, ASLAN Galip Servet, MO Li, WU Qifang, CLAUSS Sebastian, KOCABAŞ Fatih

Primary Institution: Regenerative Nanomedicine, INSERM-University of Strasbourg, Strasbourg, France

Hypothesis

Inhibition of MEIS1 enhances cardiomyocyte proliferation and cytokinesis.

Conclusion

Inhibition of MEIS1 significantly increases the proliferation of cardiomyocytes and shows potential for cardiac regeneration.

Supporting Evidence

  • MEIS1 inhibition increased the proportion of proliferating cardiomyocytes up to 4.5-fold.
  • MEIS1 inhibitors showed no adverse effects on cell viability during the study.
  • Extended treatment with MEIS inhibitors led to a significant upregulation of cardiac-specific genes.

Takeaway

This study shows that blocking a specific gene can help heart cells grow and divide better, which might help heal damaged hearts.

Methodology

The study involved using two small molecules to inhibit MEIS1 and assessing their effects on cardiomyocyte proliferation and cytokinesis in neonatal and adult heart cells.

Limitations

The study primarily focuses on in vitro results and may not fully translate to in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.55730/1300-0152.2716

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication